Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ledoux

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Hematological Oncology|December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registryPellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Journal of Hematology & Oncology|October 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|February 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Eclinicalmedicine|March 27, 2024
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022Jon Salmanton-García, Francesco Marchesi, Francesca Farina, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Hematological Oncology|December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registryPellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Journal of Hematology & Oncology|October 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|February 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Eclinicalmedicine|March 27, 2024
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022Jon Salmanton-García, Francesco Marchesi, Francesca Farina, et al.
Pageof 5